Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C60H96N20O21S2 |
| Molecular Weight | 1497.656 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 19 / 19 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H](NC(=O)C1=NC(=NC(N)=C1C)[C@H](CC(N)=O)NC[C@H](N)C(N)=O)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2O[C@H]3O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]3O)C4=CN=CN4)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCCNCCCCNCCCN
InChI
InChIKey=FOUFFVYWFNBHHH-YNGSZULRSA-N
InChI=1S/C60H96N20O21S2/c1-25-38(77-51(80-49(25)64)30(17-36(63)84)72-18-29(62)50(65)90)55(94)79-40(46(31-19-69-24-73-31)99-59-48(44(88)42(86)34(20-81)98-59)100-58-45(89)47(101-60(66)96)43(87)35(21-82)97-58)56(95)74-27(3)41(85)26(2)52(91)78-39(28(4)83)54(93)71-16-9-37-75-33(23-102-37)57-76-32(22-103-57)53(92)70-15-8-14-68-12-6-5-11-67-13-7-10-61/h19,22-24,26-30,34-35,39-48,58-59,67-68,72,81-83,85-89H,5-18,20-21,61-62H2,1-4H3,(H2,63,84)(H2,65,90)(H2,66,96)(H,69,73)(H,70,92)(H,71,93)(H,74,95)(H,78,91)(H,79,94)(H2,64,77,80)/t26-,27+,28+,29-,30-,34-,35+,39-,40-,41-,42+,43+,44-,45-,46-,47-,48-,58+,59-/m0/s1
Bleomycin A6 (also known as boanmycin) was developed in China as an antineoplastic antibiotic. This drug participated in clinical trials for the treatment of Squamous Cell Lung Cancer. It was shown that besides the antitumor effect, Bleomycin A6 had the ability to alter the tumor microenvironment and could contribute toward lung cancer relapse and metastasis on long-term treatment. The development of this drug, apparently, was discontinued.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000019152
Created by
admin on Mon Mar 31 21:07:33 GMT 2025 , Edited by admin on Mon Mar 31 21:07:33 GMT 2025
|
PRIMARY | |||
|
DB12992
Created by
admin on Mon Mar 31 21:07:33 GMT 2025 , Edited by admin on Mon Mar 31 21:07:33 GMT 2025
|
PRIMARY | |||
|
37293-17-7
Created by
admin on Mon Mar 31 21:07:33 GMT 2025 , Edited by admin on Mon Mar 31 21:07:33 GMT 2025
|
PRIMARY | |||
|
9877229
Created by
admin on Mon Mar 31 21:07:33 GMT 2025 , Edited by admin on Mon Mar 31 21:07:33 GMT 2025
|
PRIMARY | |||
|
DTXSID001318678
Created by
admin on Mon Mar 31 21:07:33 GMT 2025 , Edited by admin on Mon Mar 31 21:07:33 GMT 2025
|
PRIMARY | |||
|
0B19OCB220
Created by
admin on Mon Mar 31 21:07:33 GMT 2025 , Edited by admin on Mon Mar 31 21:07:33 GMT 2025
|
PRIMARY | |||
|
C052656
Created by
admin on Mon Mar 31 21:07:33 GMT 2025 , Edited by admin on Mon Mar 31 21:07:33 GMT 2025
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD